Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Myriad Genetics Inc (NASDAQ:MYGN)

20.63
Delayed Data
As of 3:59pm ET
 -0.42 / -2.00%
Today’s Change
19.10
Today|||52-Week Range
46.24
-52.20%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues613.2M778.2M723.1M753.8M
 
 
 
 
 
Cost of Goods Sold70.7M95.4M122.4M130.6M
 
 
 
 
 
Depreciation And Amortization8.9M13.8M25.0M26.7M
 
 
 
 
 
 
Operating ExpensesGross Income533.5M669.0M575.7M596.5M
 
 
 
 
 
General Expenses304.1M394.6M441.5M429.7M
 
 
 
 
 
Research And Development52.2M67.5M75.5M70.6M
 
 
 
 
 
Total Operating Expenses383.7M503.8M588.9M587.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income229.5M274.4M134.2M166.8M
 
 
 
 
 
Extraordinary Charge-1.5M0.00--0.00
 
 
Other Expenses-223.0K-2.0M300.0K1.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income233.3M277.9M134.9M168.9M
 
 
 
 
 
Income Taxes-86.1M-101.6M-54.7M-43.6M
 
 
 
 
 
Net Income147.1M176.2M80.2M125.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS80.9M75.7M71.3M70.0M
 
 
 
 
 
Shares To Calculate EPS Diluted83.3M78.2M74.5M73.4M
 
 
 
 
 
 
Earnings Per ShareEPS$1.77$2.25$1.08$1.71
 
 
 
 
 
EPS Diluted$1.77$2.25$1.08$1.71